Ingalls & Snyder LLC Medtronic PLC Transaction History

Ingalls & Snyder LLC

  • $2.55 Billion
  • Q4 2024

A detailed history of Ingalls & Snyder LLC transactions in Medtronic PLC stock. As of the latest transaction made, Ingalls & Snyder LLC holds 21,498 shares of MDT stock, worth $1.93 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
21,498
Previous 29,198 26.37%
Holding current value
$1.93 Million
Previous $2.63 Million 34.69%
% of portfolio
0.07%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$79.61 - $92.24 $612,997 - $710,248
-7,700 Reduced 26.37%
21,498 $1.72 Million
Q3 2024

Nov 14, 2024
BUY
$76.84 - $91.03 $537,034 - $636,208
6,989 Added 31.47%
29,198 $2.63 Million
Q2 2024

Jul 31, 2024
SELL
$78.71 - $87.02 $98,623 - $109,036
-1,253 Reduced 5.34%
22,209 $1.75 Million
Q1 2024

May 13, 2024
BUY
$82.84 - $88.09 $2,568 - $2,730
31 Added 0.13%
23,462 $2.05 Million
Q4 2023

Jan 29, 2024
SELL
$69.43 - $83.43 $27,077 - $32,537
-390 Reduced 1.64%
23,431 $1.93 Million
Q3 2023

Nov 02, 2023
SELL
$78.22 - $90.4 $33,243 - $38,420
-425 Reduced 1.75%
23,821 $1.87 Million
Q2 2023

Jul 27, 2023
BUY
$79.47 - $91.38 $51,655 - $59,397
650 Added 2.75%
24,246 $2.14 Million
Q4 2022

Jan 31, 2023
SELL
$76.18 - $87.74 $456,851 - $526,176
-5,997 Reduced 20.26%
23,596 $1.83 Million
Q3 2022

Oct 21, 2022
SELL
$80.75 - $95.31 $100,533 - $118,660
-1,245 Reduced 4.04%
29,593 $2.39 Million
Q2 2022

Aug 11, 2022
SELL
$87.4 - $113.09 $92,032 - $119,083
-1,053 Reduced 3.3%
30,838 $2.77 Million
Q1 2022

May 09, 2022
SELL
$100.58 - $112.38 $82,978 - $92,713
-825 Reduced 2.52%
31,891 $3.54 Million
Q4 2021

Feb 11, 2022
SELL
$99.53 - $127.75 $114,459 - $146,912
-1,150 Reduced 3.4%
32,716 $3.38 Million
Q3 2021

Oct 27, 2021
SELL
$122.75 - $135.17 $165,958 - $182,749
-1,352 Reduced 3.84%
33,866 $4.25 Million
Q2 2021

Aug 03, 2021
BUY
$118.19 - $131.5 $25,529 - $28,404
216 Added 0.62%
35,218 $4.37 Million
Q1 2021

Apr 21, 2021
BUY
$111.18 - $119.74 $22,013 - $23,708
198 Added 0.57%
35,002 $4.14 Million
Q4 2020

Jan 27, 2021
SELL
$100.57 - $117.14 $10,962 - $12,768
-109 Reduced 0.31%
34,804 $4.08 Million
Q3 2020

Oct 21, 2020
BUY
$90.13 - $108.78 $31,004 - $37,420
344 Added 1.0%
34,913 $3.63 Million
Q2 2020

Jul 31, 2020
SELL
$84.11 - $103.33 $259,227 - $318,463
-3,082 Reduced 8.19%
34,569 $3.17 Million
Q1 2020

Apr 22, 2020
SELL
$72.92 - $121.3 $281,762 - $468,703
-3,864 Reduced 9.31%
37,651 $3.4 Million
Q4 2019

Jan 15, 2020
SELL
$104.49 - $114.54 $29,466 - $32,300
-282 Reduced 0.67%
41,515 $4.71 Million
Q3 2019

Oct 16, 2019
SELL
$98.02 - $111.18 $148,990 - $168,993
-1,520 Reduced 3.51%
41,797 $4.54 Million
Q2 2019

Jul 11, 2019
SELL
$84.15 - $99.38 $710,310 - $838,866
-8,441 Reduced 16.31%
43,317 $4.22 Million
Q1 2019

Apr 11, 2019
SELL
$82.45 - $93.79 $515,312 - $586,187
-6,250 Reduced 10.77%
51,758 $4.71 Million
Q4 2018

Jan 24, 2019
BUY
$85.8 - $99.49 $184,899 - $214,400
2,155 Added 3.86%
58,008 $5.28 Million
Q3 2018

Oct 24, 2018
BUY
$85.91 - $99.17 $4.47 Million - $5.16 Million
52,070 Added 1376.42%
55,853 $5.49 Million
Q2 2018

Aug 10, 2018
SELL
$77.48 - $87.83 $41,064 - $46,549
-530 Reduced 12.29%
3,783 $324,000
Q1 2018

Apr 17, 2018
SELL
$76.55 - $87.26 $4,363 - $4,973
-57 Reduced 1.3%
4,313 $346,000
Q4 2017

Jan 19, 2018
SELL
$76.93 - $83.5 $23,155 - $25,133
-301 Reduced 6.44%
4,370 $353,000
Q3 2017

Oct 20, 2017
BUY
$77.71 - $84.6 $362,983 - $395,166
4,671
4,671 $363,000

Others Institutions Holding MDT

# of Institutions
2,350
Shares Held
1.05B
Call Options Held
7M
Put Options Held
7.22M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email